Repression Of TGF-Β Signaling In Breast Cancer Cells By MiR-302/367 Cluster

Objective: Tumor necrosis factor-alpha (TNF-α), checkpoint inhibitors, and interleukin-17 (IL-17) are critical targets in inflammation and autoimmune diseases. Monoclonal antibodies (mAbs) have a successful portfolio in the treatment of chronic diseases. With the current progress in stem cells and...

Descripció completa

Dades bibliogràfiques

Autors principals:	Mona Ahmadalizadeh Khanehsar, Moslem Hoseinbeyki, Masoumeh Fakhr Taha, Arash Javeri
Format:	Artigo
Idioma:	Inglês
Publicat:	Royan Institute (ACECR), Tehran 2019-08-01
Col·lecció:	Cell Journal
Matèries:	Gene Therapy Genetic Vectors Monoclonal Antibody Secukinumab Stem Cells
Accés en línia:	https://celljournal.org/journal/article/fulltext/repression-of-tgf-beta-signaling-in-breast-cancer-cells-by-mir-302-367-cluster.pdf
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!